Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Position Trimmed by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lowered its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 16.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,191,091 shares of the biopharmaceutical company’s stock after selling 226,204 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Lexicon Pharmaceuticals were worth $880,000 […]
Charles Schwab Investment Management Inc. lowered its stake in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 16.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,191,091 shares of the biopharmaceutical company’s stock after selling 226,204 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Lexicon Pharmaceuticals were worth $880,000 […]
